Business Services

Adaptive Biotechnologies

$67.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.73 (+1.09%) Today
$0.00 (0.00%) As of 9:14 AM UTC after-hours

Why Robinhood?

You can buy or sell ADPT and other stocks, options, and ETFs commission-free!

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA. The listed name for ADPT is Adaptive Biotechnologies Corporation Common Stock.

CEO
Chad Robins
Employees
453
Headquarters
Seattle, Washington
Founded
2009
Market Cap
9.24B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
920.68K
High Today
$68.13
Low Today
$65.81
Open Price
$66.71
Volume
293.17K
52 Week High
$71.25
52 Week Low
$15.19

Collections

ADPT Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 24, After Hours

You May Also Like

SHE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure